ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

Strong balance sheet of $245.0 million in cash, cash equivalents and short-term investments supports operating plan through anticipated cash-flow break-even Conference call to be held today, March 9, ...

U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million in ...

After a coroner concluded 16-year-old Australian died of a bite-induced meat allergy, we look at how to spot symptoms and preventative measures ...

Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.

ARS Pharmaceuticals (NASDAQ:SPRY) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline early commercial progress for neffy, its needle-free epinephrine option for ...

Gü Indulgent Foods is recalling Gü Blonde Chocolate Cheesecake because it has been mispacked with a cheesecake that contains ...

A popular dessert has been recalled with a warning some people shouldn't eat it. Gü Indulgent Foods is recalling Gü Blonde Chocolate Cheesecake because it has been mispacked with a cheesecake that ...

SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect ...

EpiPens to be stocked in schools for emergency use after death of five year old boy - Helen Blythe, whose son Benedict died in 2021, said the new requirements will make it “less likely for other famil ...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good day, and thank you ...